Men diagnosed with both thyroid and prostate cancer actually survive better than those with either cancer alone.

In a SEER database study of 916,151 men, those with both thyroid and prostate cancer had lower all-cause and cancer-specific mortality than men with either cancer alone. TC+PC patients had 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only, and 17% lower all-cause…

Share
Men diagnosed with both thyroid and prostate cancer actually survive better than those with either cancer alone.

Men diagnosed with both thyroid and prostate cancer actually survive better than those with either cancer alone.

In a SEER database study of 916,151 men, those with both thyroid and prostate cancer had lower all-cause and cancer-specific mortality than men with either cancer alone. TC+PC patients had 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only, and 17% lower all-cause mortality and 38% lower PC-specific mortality vs PC-only.

Key Findings

  • TC+PC: 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only
  • TC+PC: 17% lower all-cause mortality and 38% lower PC-specific mortality vs PC-only
  • Results confirmed by competing risk models and propensity-score matching
  • Analysis drew from 916,151 men in SEER 2000-2021

Implications

Dual cancer history warrants consideration in prognostic evaluation. Mechanisms need investigation.

Caveats

Retrospective SEER database; abstract-only. Causal mechanisms unexplained; healthcare surveillance bias possible.

Source: Medical science monitor : international medical journal of experimental and clinical research — 2026-04-12

Read more